ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,116.17
0.32%
Dow Jones
38,386.09
0.00%
US Dollar vs MXN
16.96455
-0.29%
Brent Oil
87.705
0.48%
Bitcoin
60,943.99
-4.53%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Vertex Pharmaceuticals Inc (VRTX)

  7. Vertex Pharmaceuticals Inc (VRTX) Noticias

VRTX Vertex Pharmaceuticals Inc

396.20
0.00 (0.00%)
Pre Mercado
Última actualización: 06:56:34
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Vertex Pharmaceuticals Inc VRTX NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 396.20 06:56:34
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
396.20
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
26/4/202410:43BWVertex Announces European Commission Approval for KALYDECO®..
22/4/202423:45PRNUSVERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING..
18/4/202407:00BWVertex Announces Advancements of Suzetrigine (VX-548) in..
11/4/202406:24IHMARKETNEWSCostco Increases Dividend by 14%, Meta Introduces ‘Artemis’..
10/4/202415:01BWVertex Enters Into Agreement to Acquire Alpine Immune..
09/4/202415:05BWVertex to Announce First Quarter 2024 Financial Results on..
01/4/202410:00PRNCAVertex annonce que la présentation de drogue nouvelle..
01/4/202407:00BWVertex Advances Inaxaplin (VX-147) into Phase 3 Portion of..
21/3/202407:00BWVertex Announces FDA Clearance of Investigational New Drug..
27/2/202416:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202412:19EDGAR2Form 144 - Report of proposed sale of securities
26/2/202410:25EDGAR2Form 144 - Report of proposed sale of securities
26/2/202410:10EDGAR2Form 144 - Report of proposed sale of securities
26/2/202409:52EDGAR2Form 144 - Report of proposed sale of securities
26/2/202409:44EDGAR2Form 144 - Report of proposed sale of securities
26/2/202409:26EDGAR2Form 144 - Report of proposed sale of securities
23/2/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202415:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202406:10BWVertex Receives CHMP Positive Opinion for KALYDECO® for the..
21/2/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202410:38EDGAR2Form 144 - Report of proposed sale of securities
21/2/202409:52EDGAR2Form 144 - Report of proposed sale of securities
21/2/202409:44EDGAR2Form 144 - Report of proposed sale of securities
21/2/202409:16EDGAR2Form 144 - Report of proposed sale of securities
21/2/202408:50EDGAR2Form 144 - Report of proposed sale of securities
21/2/202408:43EDGAR2Form 144 - Report of proposed sale of securities
20/2/202415:05BWVertex to Participate in Upcoming Investor Conferences
20/2/202410:29EDGAR2Form 144 - Report of proposed sale of securities
20/2/202410:03EDGAR2Form 144 - Report of proposed sale of securities
20/2/202409:57EDGAR2Form 144 - Report of proposed sale of securities
20/2/202409:32EDGAR2Form 144 - Report of proposed sale of securities
20/2/202409:22EDGAR2Form 144 - Report of proposed sale of securities
20/2/202409:22EDGAR2Form 144 - Report of proposed sale of securities

Su Consulta Reciente

NASDAQ
VRTX
Vertex Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados